Elevra Lithium (ASX:ELV) produced 44,154 dry metric tonnes (dmt) and sold 66,016 dmt of spodumene concentrate during the fiscal second quarter ended Dec. 31, 2025, from its North American Lithium operations in Canada, according to a Wednesday filing with the Australian bourse.
The concentrate was sold at an average realized price of $998 per dmt to earn revenue of $66 million during the quarter, the filing said.
In the December 2024 quarter, the company produced 50,922 dmt and sold 66,035 dmt of concentrate concentrate.
For fiscal 2026, the company lowered its spodumene concentrate production guidance to a range of 180,000 dmt to 190,000 dmt from its previous guidance of 195,000 dmt to 210,000 dmt, the filing added.
It also lowered its fiscal 2026 spodumene concentrate sales guidance to a range of 170,000 dmt to 190,000 dmt from its prior forecast of 195,000 dmt to 210,000 dmt.
The company raised its unit operating cost guidance for the fiscal year to $860 to $880 per dmt, up from its previous guidance of $765 to $830 per dmt.
Shares of the company fell nearly 10% in recent Wednesday trade.